Navigation Links
LifeCare Holdings, Inc. Announces Third Quarter Results
Date:11/13/2009

PLANO, Texas, Nov. 13 /PRNewswire/ -- LifeCare Holdings, Inc. (the "Company") today announced its operating results for the quarter ended September 30, 2009.

Three Months Ended September 30, 2009

Net Revenues

Our net patient service revenue increased by $1.9 million, or 2.3%, for the three months ended September 30, 2009, to $84.3 million from $82.4 million for the comparable period in 2008. Patient days and admissions decreased by 4.4% and 7.2%, respectively, during the three months ended September 30, 2009 as compared to the same period in 2008.

The $1.9 million increase in net patient service revenue was comprised of a $0.2 million increase in adjustments related to changes in estimates and settlements on cost reports previously filed with the Medicare program, offset by an unfavorable variance of $3.7 million attributable to the decrease in patient days, with a remaining increase of $5.4 million attributable to an increase in revenue per patient day.

During the three months ended September 30, 2009 our net patient service revenue per patient day was $1,594, as compared to $1,489 for the 2008 period, an increase of 7.1%. The increase in net patient service revenue on a per patient day basis during the 2009 period was primarily the result of annual inflationary increases in our standard charge rates and certain of our contracts with commercial payors, a higher acuity level of the patients treated in the 2009 period, and the marginal increases contained in recent annual regulatory updates implemented by CMS during 2008.

Expenses

Total expenses decreased by $1.9 million to $85.6 million for the three months ended September 30, 2009 as compared to $87.5 million for the comparable period in 2008. The decrease of $1.9 million was primarily the result of a decrease of $0.5 million in salaries, wages and benefits, a decrease of $1.6 mil
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
2. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
3. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
4. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
5. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
6. Telik Announces Third Quarter 2009 Financial Results
7. Quantros Announces Partnership With Hospital Accreditation Agency DNV
8. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
9. Dynatronics Announces Positive Financial Results for Quarter
10. Niusule Announces Key Additions to Management Team
11. Warner Chilcott Announces Secondary Equity Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ConvaTec, a privately-held medical products ... been appointed Interim Chief Executive Officer of the company, ... Ken Berger .  "The Board of Directors of ... ConvaTec over the past three years," said Magnus ... "We are confident that the company is well positioned ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
(Date:12/22/2014)... Dec. 22, 2014  Mark Farrah Associates (MFA), ... a summary of the 2015 marketplace exchange projections ... According to a recent ASPE ... Evaluation, Department of Health and Human Services) report, ... individual medical plans through the Marketplace as of ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2
... September 2 , - CAPRA-2-Data ... Nitec Pharma AG ("Nitec" or "Nitec ... commercialization of,medicines to treat chronic inflammation and pain-related diseases, today,announced ... its,lead product, Lodotra(TM). , The CAPRA-2 ...
... , , , ... Park, Ph. D., Head of Process Sciences at aTyr Pharma, a ... newly emerging class of natural biotherapeutics, will be a featured speaker ... will present his talk "Selecting the Optimal Biotherapeutic Candidate for Development" ...
Cached Medicine Technology:Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA 2Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA 3Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009 2
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven ... and durability. Today, the business announces a click ... until Jan. 30, 2015. , Click strand woven ... BambooFlooringChina.com is a well-known brand in the bamboo ... find a reliable bamboo flooring supplier. , “We ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... which is typically used for treating colorectal cancer. It ... gastric cancer and pancreatic cancer. TS-1 is composed of ... approved in 1999 in Japan for the treatment of ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Dec. ... the world more people are suffering from acid reflux, likely ... a new study suggests. In Norway, the prevalence of ... almost 50 percent in the past 10 years, say researchers ...
... medical test results and other clinical measurements is ... common terminology to ensure that medical data can ... where the patient needs it. A reference ... frequently reported laboratory test observations, released by the ...
... WEDNESDAY, Dec. 21 (HealthDay News) -- New research suggests that ... people who may be destined to develop Alzheimer,s disease, but ... people fend off dementia. Still, the findings could help ... progression of the disease, said study co-author Dr. Brad Dickerson, ...
... Reporter , WEDNESDAY, Dec. 21 (HealthDay News) -- Problems in ... be at the heart of this learning disorder, new research ... issue of the journal Neuron , may one day ... diagnosed with this common yet still ultimately mysterious condition. ...
... HealthDay Reporter , WEDNESDAY, Dec. 21 (HealthDay News) ... shakes and soup followed by adding low-calorie, high-protein foods ... may lessen joint pain and improve their quality of ... also help people whose obesity makes it impossible to ...
... WEDNESDAY, Dec. 21 (HealthDay News) -- Ludwig van Beethoven was arguably ... yet he was deaf by the end of his career. ... suggests that the progression of his deafness may have shaped ... the Netherlands analyzed three styles of Beethoven,s compositions. In a letter ...
Cached Medicine News:Health News:As Obesity Rises, More Suffer From Acid Reflux 2Health News:Lingua franca critical for electronic medical records and health information exchange 2Health News:Thinner Brains Could Signal Alzheimer's, Study Suggests 2Health News:Scientists Probe the Origins of Dyslexia 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 3Health News:Did Beethoven's Hearing Loss Shape His Compositions? 2
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... The InfusO.R. Pump is a ... aid in the administration of ... anesthetic procedures. It provides for ... muscle relaxants, and vasoactive drugs ...
... The Ipump Pain Management System answers ... environment with one-on-one flexibility. From programming ... puts customizable pain management right where ... system is designed to help each ...
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: